Applied Therapeutics Inc (NASDAQ: APLT) is 69.25% higher on its value in year-to-date trading and has touched a low of $1.18 and a high of $9.39 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The APLT stock was last observed hovering at around $5.63 in the last trading session, with the day’s gains setting it 0.04%.
Currently trading at $5.67, the stock is 17.40% and 22.10% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.97 million and changing 0.71% at the moment leaves the stock 43.66% off its SMA200. APLT registered 303.56% gain for a year compared to 6-month gain of 126.80%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 12.28% loss in the last 1 month and extending the period to 3 months gives it a 10.10%, and is 8.21% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.07% over the week and 6.76% over the month.
Applied Therapeutics Inc (APLT) has around 25 employees, a market worth around $647.91M and $10.66M in sales. Profit margin for the company is -905.38%. Distance from 52-week low is 380.51% and -39.62% from its 52-week high. The company has generated returns on investments over the last 12 months (-143.35%).
The EPS is expected to grow by 12.40% this year
The shares outstanding are 114.27M, and float is at 88.20M with Short Float at 7.16%.
Applied Therapeutics Inc (APLT) Insider Activity
The most recent transaction is an insider sale by Shendelman Shoshana, the company’s President and CEO. SEC filings show that Shendelman Shoshana sold 61,795 shares of the company’s common stock on Jun 06 ’24 at a price of $4.32 per share for a total of $0.27 million. Following the sale, the insider now owns 3.76 million shares.
Applied Therapeutics Inc disclosed in a document filed with the SEC on Jun 06 ’24 that Perfetti Riccardo (Chief Medical Officer) sold a total of 22,003 shares of the company’s common stock. The trade occurred on Jun 06 ’24 and was made at $4.32 per share for $95053.0. Following the transaction, the insider now directly holds 1.01 million shares of the APLT stock.
Still, SEC filings show that on Jun 06 ’24, Funtleyder Leslie D. (Chief Financial Officer) disposed off 16,980 shares at an average price of $4.32 for $73354.0. The insider now directly holds 291,441 shares of Applied Therapeutics Inc (APLT).
